Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06382389
Other study ID # DR220204
Secondary ID 2023-504691-18-0
Status Not yet recruiting
Phase Phase 2
First received
Last updated
Start date June 2024
Est. completion date August 2026

Study information

Verified date April 2024
Source University Hospital, Tours
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Depression in neurocognitive disorders (Alzheimers' disease and related disoders) is a highly prevalent condition, especially in nursing homes. While it is associated with significant distress, the current conventional antidepressants have shown only modest efficacy and exposed to potentially severe side effects. Recent evidence suggests that nitrous oxide (N2O) in its most commonly used packaging of EMONO (Equimolar Mixture of Oxygen and Nitrous Oxide) has rapid antidepressant properties and a good safety profile. However, no study has investigating the antidepressant effect of EMONO in a population of depressed older adults with moderate to severe neurocognitive disorders in nursing homes. The principal goal of the PROTO-EHPAD study is to compare the changes in depressive symptoms in such individuals in a randomized controlled trial with a follow up period of 8 weeks, with a dosage escalation procedure.


Description:

Participants will be exposed to 3 sessions of EMONO (or Medical Air), with intervals of 1 week between sessions : a first session of 20 minutes, a second of 40 minutes one week later and a final session of 60 minutes one week later. Efficacy will be assessed 1 week after each session and 4 weeks after the last session.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 96
Est. completion date August 2026
Est. primary completion date August 2026
Accepts healthy volunteers No
Gender All
Age group 60 Years and older
Eligibility Inclusion Criteria: - Men and women aged 60 and over living in nursing home - Diagnosis of major neurocognitive disorder according to DSM-V for at least 6 month - MMSE <= 20/30 - NPI depression >= 4/12 - Patient, family and legal representive consent where applicable Person affiliated to a social security schem Exclusion Criteria: - NPI agitation > 6/12 - Unstable somatic pathology (in particular unstable neurological or cardiological pathologies at risk of interfering with the diffusion of MEOPA) and any unexplained recent neurological abnormality. - Contraindications to the use of MEOPA - Patients who have already been treated with MEOPA in the 6 months prior to inclusion, for example for painful treatment - Sub-physiological plasma vitamin B12 or B9 concentration (below the lower limit of the laboratory value). - A person participating in a clinical drug study or in a period of exclusion from any clinical study due to previous participation - Personne participant à une étude clinique médicamenteuse ou en période d'exclusion de toute étude clinique du fait d'une précédente participation

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
EMONO
Exposure of Emono via facial mask
Medical air
exposure to Medical Air

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Tours

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in the CORNELL depression severity´ scale between S4 (one week after the last administration of MEOPA or medical air) and S1 (baseline). The CORNELL is a validated scale specifically designed for depression in major neurocognitive disorders baseline, week 4
Secondary CORNELL scale and GDS scale at weeks 1, 2, 3, 4 and 8 The Geriatric Depression Scale is a self assessed scale for depression in older individuals baseline, weeks 1, 2, 3, 4 and 8
Secondary CGI-S and CGI-I scales at weeks 1, 2, 3, 4 and 8 CGI assesses the clinical global impression of the clinician baseline, weeks 1, 2, 3, 4 and 8
Secondary The measurement of well-being by the EVIBE visual analogue scale at weeks 1, 2, 3, 4, and 8 EVIBE is a visual analog scale specifically designed to measure well being in major cognitive disorders baseline, weeks 1, 2, 3, 4 and 8
Secondary Collection of adverse events at all study visits any adverse events will be collected baseline, weeks 1, 2, 3, 4 and 8
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A